Pediatric inflammatory bowel diseases: Coming of age

Current Opinion in Gastroenterology

Volumn 26, Issue 4, 2010, Pages 332-336

  Ruemmele, Frank M ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Crohn's disease; Epidemiology; IL10 signaling; Pediatric IBD; Susceptibility genes

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 27; C19ORF10 PROTEIN, HUMAN; DECOY RECEPTOR 3; IL27 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; TNFRSF6B PROTEIN, HUMAN;

AUTOPHAGY; CHILD; CHILDHOOD; CROHN DISEASE; DRUG EFFICACY; ENTERITIS; GENETIC PREDISPOSITION; GROUPS BY AGE; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; INCIDENCE; INNATE IMMUNITY; ONSET AGE; PRESCHOOL CHILD; PREVALENCE; REMISSION; REVIEW; SCHOOL CHILD; ULCERATIVE COLITIS; GENETICS; GENOTYPE; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; PHENOTYPE; SIGNAL TRANSDUCTION;

AGE OF ONSET; CHILD; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNITY, HUMORAL; INCIDENCE; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKINS; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; SIGNAL TRANSDUCTION;

EID: 77954133316     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328339ec2d     Document Type: Review

References (40)

1. Xavier R, Podolsky D. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427-434. (Pubitemid 47123518)
2. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361:2066-2078.
3. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
4. Ogura Y, Bonen DK, Inohara N, et al. Aframeshift mutationin NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-606.
5. Wellcome Trust Case Control Consortium. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447:661-678.
6. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40:955-962.
7. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314:1461-1463.
8. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009; 31:401-411.
9. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6:8-15.
10. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55:749-753.
11. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population based study. J Pediatr 2003; 143: 525.
12. Logan RF. Inflammatory bowel disease incidence: up, down or unchanged? Gut 1998; 42:309-311.
13. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114:1161-1168.
14. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008; 135:1106-1113.
15. Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009; 58:1490-1497.
16. Nerich V, Monnet E, Etienne A, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 2006; 12:218-226.
17. Malaty HM, Fan X, Opekun AR, et al. Rising incidence of inflammatory bowel disease among children: at 12 year study. J Pediatr Gastroenterol Nutri 2010; 50:27-31.
18. Castro M, Papadatou B, Baldassare M, et al. Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register. Inflamm Bowel Dis 2008; 14:1246-1252.
19. Orel R, Kamhi T, Vidmar G, Mamula P. Epidemiology of pediatric chronic inflammatory bowel disease in central and western Slovenia 1994-2005. J Pediatr Gastroenterol Nutr 2009; 48:579-586.
20. Van Limbergen J, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood onset inflammatory bowel disease. Gastroenterology 2008; 135:1114-1122.
21. Louis E, Louis E, Collard A, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern overthe course of the disease. Gut 2001; 49:777-782.
22. Pigneur B, Seksik P, Viola S, et al. Natural history of Crohn's disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis 2009 [Epub].
23. Punati J, Markowitz J, Lerer T, et al. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis 2008; 14: 949-959.
24. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119:895-902.
25. Sagiv-Friedgut K, Karban A, Weiss B, et al. Early-onset Crohn disease is associated with male sex and a polymorphism in the IL6 promoter. J Pediatr Gastroenterol Nutr 2010; 50:22-26.
26. Dubinsky MC, Kugathasan S, Mei L, et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol 2008; 6:1105-1111.
27. Markowitz J, Kugathasan S, Dubinsky M, et al. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology? Inflamm Bowel Dis 2009; 15:714-719.
28. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39:207-211. (Pubitemid 46184351)
29. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007; 39:830-832.
30. Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008; 40:1319-1323.
31. Kugathasan S, Baldassano RN, Bradfield JP, et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008; 40:1211-1215.
32. Amre DK, Mack DR, Morgan K, et al. Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohn's disease in Canadian children. Am J Gastroenterol 2009; 104:2824-2828.
33. Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009;41:1335-1340.
34. Essers JB, Lee JJ, Kugathasan S, et al. Established genetic risk factors do not distinguish early and late onset Crohn's disease. Inflam Bowel Dis 2008; 15:1508-1514.
35. Sanchez R, Levy E, Costea F, Sinnett D. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J Gastroenterol 2009; 15:3776-3782.
36. Krupoves A, Seidman EG, Mack D, et al. Associations between ABCB1/ MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population. Inflamm Bowel Dis 2009; 15:900-908.
37. Latiano A, Palmieri O, Cucchiara S, et al. Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol 2009; 104:110-116.
38. Dubinsky MC, Mei L, Friedman M, et al. Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2009. [Epub ahead of print].
39. Ruemmele FM, El Khoury MG, Talbotec C, et al. Characteristics and outcome of inflammatory bowel disease with onset during the first weeks and months of life. J Ped Gastroenterol Nutr 2006; 43:603-609.
40. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009; 361:2033-2045.